SK31899A3 - Expression system of neurotrophic factor and pharmaceutical composition containing such expression system - Google Patents

Expression system of neurotrophic factor and pharmaceutical composition containing such expression system Download PDF

Info

Publication number
SK31899A3
SK31899A3 SK318-99A SK31899A SK31899A3 SK 31899 A3 SK31899 A3 SK 31899A3 SK 31899 A SK31899 A SK 31899A SK 31899 A3 SK31899 A3 SK 31899A3
Authority
SK
Slovakia
Prior art keywords
expression
composition
nucleic acid
expression system
neurotrophic factor
Prior art date
Application number
SK318-99A
Other languages
English (en)
Slovak (sk)
Inventor
Georg Haase
Axel Kahn
Philippe Kennel
Jacques Mallet
Frederic Revah
Original Assignee
Rhone Poulenc Rorer Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa, Inst Nat Sante Rech Med filed Critical Rhone Poulenc Rorer Sa
Publication of SK31899A3 publication Critical patent/SK31899A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
SK318-99A 1996-09-13 1997-09-10 Expression system of neurotrophic factor and pharmaceutical composition containing such expression system SK31899A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9611186A FR2753379B1 (fr) 1996-09-13 1996-09-13 Methode de traitement de la sclerose laterale amyotrophique
PCT/FR1997/001589 WO1998011213A1 (fr) 1996-09-13 1997-09-10 Methode de traitement de la sclerose laterale amyotrophique

Publications (1)

Publication Number Publication Date
SK31899A3 true SK31899A3 (en) 1999-10-08

Family

ID=9495715

Family Applications (1)

Application Number Title Priority Date Filing Date
SK318-99A SK31899A3 (en) 1996-09-13 1997-09-10 Expression system of neurotrophic factor and pharmaceutical composition containing such expression system

Country Status (16)

Country Link
US (1) US6723315B1 (fr)
EP (1) EP0929671A1 (fr)
JP (1) JP2001504088A (fr)
KR (1) KR20010029506A (fr)
CN (1) CN1155706C (fr)
AU (1) AU740641B2 (fr)
BR (1) BR9711955A (fr)
CA (1) CA2259283A1 (fr)
CZ (1) CZ84799A3 (fr)
FR (1) FR2753379B1 (fr)
HU (1) HUP9903779A3 (fr)
IL (1) IL128185A0 (fr)
NO (1) NO991158D0 (fr)
SK (1) SK31899A3 (fr)
WO (1) WO1998011213A1 (fr)
ZA (1) ZA978257B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ533833A (en) * 2001-12-21 2008-01-31 Salk Inst For Biological Studi Targeted retrograde gene delivery to motor neurons
US20070049630A1 (en) * 2005-08-24 2007-03-01 Allergan, Inc. Method of using ryanodine receptor antagonists to treat amyotrophic lateral sclerosis
EP2323691A2 (fr) * 2008-07-11 2011-05-25 Glaxo Group Limited Traitement de la sclerose laterale amyotrophique avec nogo-a-antagoniste
JP2015529685A (ja) 2012-09-17 2015-10-08 ザ・リサーチ・インスティテュート・アット・ネイションワイド・チルドレンズ・ホスピタルＴｈｅ Ｒｅｓｅａｒｃｈ Ｉｎｓｔｉｔｕｔｅ Ａｔｎａｔｉｏｎｗｉｄｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ 筋萎縮性側索硬化症の処置のための組成物および方法
EP3065784A4 (fr) 2013-11-05 2017-05-10 The Research Institute at Nationwide Children's Hospital Compositions et procédés d'inhibition de nf-kb et sod-1 afin de traiter la sclérose latérale amyotrophique
EP4008356A1 (fr) * 2016-03-31 2022-06-08 University of Cincinnati Procédés et compositions pour le traitement de la sla
US20210177989A1 (en) * 2018-08-30 2021-06-17 Rowan University Methods of Treating or Preventing Amyotrophic Lateral Sclerosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
FR2688138B1 (fr) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
JPH08501686A (ja) * 1992-09-25 1996-02-27 ローン−プーラン・ロレ・ソシエテ・アノニム 中枢神経系、特に脳における細胞への外来遺伝子の転移のためのアデノウィルスベクター
FR2717496B1 (fr) * 1994-03-18 1996-04-12 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
FR2717824B1 (fr) * 1994-03-25 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
FR2724945B1 (fr) 1994-09-27 1996-12-27 Centre Nat Rech Scient Vecteurs viraux et utilisation en therapie genique
JP2002515816A (ja) 1997-06-30 2002-05-28 アバンテイス・フアルマ・エス・アー ｉｎ ｖｉｖｏ組織に核酸ベクターを最適に電気導入する装置

Also Published As

Publication number Publication date
WO1998011213A1 (fr) 1998-03-19
KR20010029506A (ko) 2001-04-06
HUP9903779A3 (en) 2002-01-28
CN1155706C (zh) 2004-06-30
NO991158L (no) 1999-03-10
HUP9903779A2 (hu) 2000-03-28
US6723315B1 (en) 2004-04-20
CA2259283A1 (fr) 1998-03-19
AU740641B2 (en) 2001-11-08
EP0929671A1 (fr) 1999-07-21
IL128185A0 (en) 1999-11-30
BR9711955A (pt) 1999-08-24
AU4212597A (en) 1998-04-02
JP2001504088A (ja) 2001-03-27
CN1225131A (zh) 1999-08-04
ZA978257B (en) 1998-03-24
FR2753379A1 (fr) 1998-03-20
NO991158D0 (no) 1999-03-10
CZ84799A3 (cs) 1999-06-16
FR2753379B1 (fr) 1998-10-30

Similar Documents

Publication Publication Date Title
Gauthier et al. Brain-derived neurotrophic factor gene delivery to muller glia preserves structure and function of light-damaged photoreceptors
US6632427B1 (en) Adenoviral-vector-mediated gene transfer into medullary motor neurons
Gravel et al. Adenoviral gene transfer of ciliary neurotrophic factor and brain-derived neurotrophic factor leads to long-term survival of axotomized motor neurons
Tai et al. Gene transfer of glial cell line-derived neurotrophic factor promotes functional recovery following spinal cord contusion
Haase et al. Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: therapeutic effects and mechanisms of action
US20030118556A1 (en) Targeted retrograde gene delivery to motor neurons
US6685934B1 (en) Recombinant adenoviruses coding for basic fibroblast growth factors (BFGF)
KR100403707B1 (ko) 글리아세포-유도 향신경인자(gdnf)를 암호화하는 재조합 아데노 바이러스
JP2013006846A (ja) 脳の神経変性疾患の治療法
SK31899A3 (en) Expression system of neurotrophic factor and pharmaceutical composition containing such expression system
US20040224409A1 (en) Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)
JP2003522160A (ja) 眼関連疾患の治療のための遺伝子治療
Huang et al. Intraocular gene transfer of ciliary neurotrophic factor rescues photoreceptor degeneration in RCS rats
WO2000028059A1 (fr) Therapie genique induite par adenovirus
EP0671879A1 (fr) Facteurs specifiques prevenant les lesions et la degenerescence retinales
Nakagawa et al. Timing of human insulin‐like growth factor‐1 gene transfer in reinnervating laryngeal muscle
US6552003B2 (en) Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF
US20020031493A1 (en) Recombinant adenoviruses coding for glial-derived cell neurotrophic factor (gdnf)
AU703793B2 (en) Recombinant adenoviruses coding for brain-derived neurotrophic factor (BDNF)
MXPA99000533A (en) Device for mixing an audio sequence with a video sequence
US6030949A (en) Macrophage stimulating protein for the treatment of pathologies of the nervous system
WO1999036559A1 (fr) Vecteurs viraux exprimant des filaments intermediaires neuronaux a auto-polymerisation et utilisation desdits vecteurs
KR20000070272A (ko) 수질 운동 뉴런 중으로의 아데노바이러스 벡터 매개-유전자전달방법
Vitro 765. The Feasibility of Herpes Simplex Virus Mediated Gene Therapy for Neurogenic Erectile Dysfunction
AU2928202A (en) Adenoviral-vector-mediated gene transfer into medullary motor neurons